Pharmaceutical Manufacturers in Hyderabad

Hyderabad's pharmaceutical sector excels in producing a variety of dosage forms, including oral solid, oral liquid and injectable treatments, making it a pivotal player in the global healthcare market. The city's manufacturers are particularly adept at handling extensive production demands, equipped with state-of-the-art facilities that comply with international standards. However, while Hyderabad is a leader in quantity and range, potential variability in quality control and innovation can pose challenges. This aspect often leaves room for discerning distributors to seek manufacturers who not only meet but exceed industry standards, ensuring reliability and cutting-edge products.

Moreover, while Hyderabad's manufacturers have a strong foothold in several therapeutic areas, their focus tends to be more on traditional generics rather than novel drug development. This focus results in a robust output that supports global supply chains but may lack the bespoke innovation required for more specialized healthcare solutions. As such, companies looking for partners in pharmaceutical manufacturing must weigh their options carefully, considering not just the capacity but also the forward-thinking approach and commitment to quality that aligns with evolving medical standards and patient needs.

AdvaCare Pharma USA AdvaCare Pharma USA is a top-tier pharmaceutical manufacturer globally recognized for maintaining the highest industry standards. It offers a vast range of products with 13 dosage forms and more than 500 treatments, serving pharmaceutical distributors, hospitals, pharmacies, and governmental bodies across over 65 nations.

AdvaCare Pharma has built its competitive edge through complete supply chain management. Its extensive facilities, flexible manufacturing techniques, and unique management systems ensure they produce affordable, high-quality drugs that healthcare professionals rely on for effective clinical care. From testing materials to the final distribution, AdvaCare Pharma’s products are trusted globally.

Gland Pharma Founded in 1978 in Hyderabad, India, Gland Pharma initially started as a contract manufacturer of small volume liquid parenteral products. Over the years, the company has expanded its operations to become a significant player in the generic injectables manufacturing sector. It has established a presence in over 60 countries, including the United States, Europe, Canada, Australia, India, and other markets. Gland Pharma primarily operates through a business-to-business (B2B) model and is involved in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The company's management structure is comprised of a professional team, and one of its promoters is Shanghai Fosun Pharma, a pharmaceutical company with a global reach.

Unichem Unichem Laboratories, established in 1944 by Mr. Amrut Mody, is a pharmaceutical company based in India. The company is involved in the development, manufacture, and sale of pharmaceutical products. It operates in various segments of the pharmaceutical industry and has a presence in both the domestic and international markets. Unichem Laboratories conducts research aimed at developing new pharmaceutical products and improving existing ones. The company's portfolio includes a range of therapeutic products, and it has established facilities that comply with regulatory standards. Over the years, Unichem Laboratories has expanded its operations and now includes a network of distribution channels that facilitate the availability of its products to a broader consumer base. The company has a history of engaging in pharmaceutical practices in India and has contributed to the sector through its research and product offerings.

Biological E. Biological E. Limited (BE) was established during the 'Swadeshi Movement' in India. The company began operations in 1953 under the leadership of Dr. DVK Raju, focusing initially on the production of biological products such as liver extracts and anti-coagulants. Over the years, Biological E. Limited shifted its focus toward disease prevention, leading to the creation of its Biotechnology Division (later renamed the Vaccines and Biologics Division). This division started the large-scale production of DPT vaccines in 1962. Today, the company has expanded its operations and now consists of three strategic business units: Branded Formulations, Specialty Generic Injectables, and Vaccines & Biologics. This diversification aligns with its ongoing evolution within the healthcare industry.

Laurus Labs Laurus Labs is a company engaged in the development and manufacturing of pharmaceutical products, focusing primarily on anti-retroviral, Hepatitis C, and Oncology drugs. The company is an active participant in the global market, distributing active pharmaceutical ingredients (APIs) to 56 countries and collaborating with the top 10 generic pharmaceutical companies worldwide. Laurus Labs emphasizes research and development, having filed 322 patents and owning 203 of them. Since its inception, the company has launched over 60 products through three main business units: Generics API, Generics FDF, and Synthesis.

The company prides itself on operating with transparency and integrity, which it believes are crucial for attracting skilled professionals and maintaining stakeholder trust. Operating in a highly regulated industry, Laurus Labs commits to exceeding international standards through a stringent compliance approach.

FDC INDIA FDC Limited is a pharmaceutical company recognized for manufacturing and distributing Electral, a treatment for dehydration. The company is committed to ensuring that its products are accessible and cost-effective, acknowledging the importance of availability in healthcare. FDC Limited emphasizes the significance of maintaining high standards of quality in its operations to support healthcare needs. The organization operates with the guiding principle that its impact on global healthcare is a priority. Staff at FDC Limited are aware of the company's mission and the role they play in achieving it. In pursuit of making healthcare more accessible, the company's team is dedicated to taking necessary actions to enhance healthcare delivery. FDC Limited positions itself as a responsive entity in the pharmaceutical industry, focusing on effective solutions for health issues such as dehydration.

Hetero Drugs Hetero Drugs, established in 1993 and headquartered in Hyderabad, India, operates as a pharmaceutical company with a presence in various global markets. The company is involved in the research, development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its facilities are equipped to produce a broad range of pharmaceutical products. The company focuses on several therapeutic areas, including oncology, HIV/AIDS, cardiovascular diseases, and central nervous system disorders. Hetero Drugs has developed a portfolio that includes complex generics and specialty pharmaceutical products aimed at meeting specific medical needs and adapting to the changing demands of healthcare systems.

Hetero Drugs prioritizes research and development as part of its operations, aiming to innovate within its product offerings. Additionally, the company adheres to industry standards of compliance, sustainability, and corporate responsibility. These efforts are part of its broader goal to support and impact global healthcare systems.

Suven Life Sciences Suven Life Sciences, based in Hyderabad, India, is a biopharmaceutical company engaged in the research and development of therapies for central nervous system (CNS) disorders. Founded in 1989, the company has focused on the discovery and development of drugs aimed at treating neurological conditions such as Alzheimer's disease, schizophrenia, Parkinson's disease, and depression. Suven Life Sciences maintains a portfolio of proprietary molecules and intellectual property rights related to these endeavors. The company's activities span medicinal chemistry, preclinical and clinical research, and regulatory affairs, aiming to address gaps in available treatments for CNS disorders.

As part of its operations, Suven Life Sciences seeks to develop and potentially commercialize new therapeutic options that meet previously unaddressed medical needs in the neuroscience sector. The company is involved in ongoing efforts to contribute to global healthcare advancements through its research and development initiatives in the pharmaceutical field.

SMS Pharma SMS Pharmaceuticals Ltd. is a pharmaceutical manufacturing company based in India. Established in 1990, the company began with a single facility focusing on one product. Over time, it has expanded into a multi-location organization, serving a variety of therapeutic segments. The company's facilities comply with cGMP (Current Good Manufacturing Practice) and WHO (World Health Organization) standards, supporting its operations in both domestic and international markets.

The company is recognized as an export house since 1997-98 and is listed on the stock exchange. Its customer base has shown growth both in India and abroad. SMS Pharmaceuticals Ltd. operates four manufacturing facilities and two research centers, employing over 1000 staff members. The company's product portfolio includes a diverse range of Active Pharmaceutical Ingredients (APIs), supported by a robust research and manufacturing team equipped with advanced facilities.

Granules India Granules India is a company that aims to provide access to medicines that are safe, effective, and affordable. The company utilizes a vertically-integrated model that has evolved from manufacturing active pharmaceutical ingredients (API) to becoming a global pharmaceutical entity. This model supports the efficient production of large-scale batches, with capacities reaching 24,640 TPA in pharmaceutical formulations intermediates (PFIs).

Additionally, Granules India benefits from robust research and development facilities. The dedicated team focuses on developing products and processes that lead to a range of cost-effective solutions. The company's product portfolio includes stable APIs, PFIs, and finished dosages (FDs), which are designed to meet the requirements of international clients. Recently, Granules India has also begun distributing products under its own label in various global markets. This expansion aims to enhance the company's presence and service in the pharmaceutical industry.

Vivimed Founded in 1991 in Hyderabad, India, Vivimed Labs evolved from a small, family-run enterprise into an international supplier of specialized molecules and formulations for the healthcare, pharmaceutical, and specialty chemicals sectors, serving approximately 50 countries. The company uses chemistry to develop ingredients that are integral to everyday human life, providing high-quality products in the markets it operates. Vivimed Labs has a significant presence in the Finished Dosage Formulation (FDF) sector and Retail Branded Formulation manufacturing, focusing on internal health applications. The company offers contract manufacturing services as well as its own branded formulations within the FDF segment.

Vivimed Labs operates four manufacturing facilities and a research and development center. It emphasizes quality and compliance across its operations. The company's manufacturing facilities, including two in Northern India and two in Southern India, are dedicated to the production of finished pharmaceutical formulations.

Wockhardt Wockhardt Limited, an Indian pharmaceutical and biotechnology company, established its US subsidiary, Wockhardt USA, in early 2004. Initially, the subsidiary had a portfolio of three FDA-approved generic products. Over the years, Wockhardt USA LLC has expanded its product offerings to include generic oral solids, liquids, topicals, and injectables. To date, the company has secured over 110 Abbreviated New Drug Application (ANDA) approvals. In October 2007, Wockhardt Limited acquired Morton Grove Pharmaceuticals, a Chicago-based company. This acquisition was part of Wockhardt's strategy to broaden its product range in the US market. Morton Grove Pharmaceuticals has been operational since 1995, specializing in the manufacture and marketing of oral liquid and topical pharmaceuticals. The company operates a 125,000 square foot facility, equipped with modern manufacturing capabilities.

AdvaCare Pharma distinguishes itself from the multitude of inadequate pharmaceutical manufacturers in India by establishing and maintaining superior standards. As a pharmaceutical firm rooted in the US, we are committed to upholding rigorous American standards for quality and management, ensuring a high degree of both reliability and safety in the multifaceted Indian market.

Our business model excels not only by providing cost-effective pharmaceutical solutions but also by offering solid support to distributors with well-established global brands and detailed marketing strategies. Capable of producing an array of 13 different dosage forms, AdvaCare Pharma is fully prepared to satisfy the exhaustive demands of hospitals, clinics, pharmacies, and healthcare providers across the globe.